Aituk7
Striker
NHS to save millions in landmark drug ruling
A landmark ruling against two leading drug companies could save the NHS "hundreds of millions" a year.
Novartis and Bayer were trying to stop NHS doctors from prescribing a cheaper treatment for a serious eye condition.
Twelve NHS bodies in the north east of England were offering patients Avastin, a cheaper alternative to the licensed drug, Lucentis.
Health bosses said the ruling may reduce the power of companies to set prices.
A landmark ruling against two leading drug companies could save the NHS "hundreds of millions" a year.
Novartis and Bayer were trying to stop NHS doctors from prescribing a cheaper treatment for a serious eye condition.
Twelve NHS bodies in the north east of England were offering patients Avastin, a cheaper alternative to the licensed drug, Lucentis.
Health bosses said the ruling may reduce the power of companies to set prices.